Skip to main content
Top
Published in: BMC Public Health 1/2006

Open Access 01-12-2006 | Technical advance

Total plasma homocysteine, folate, and vitamin b12 status in healthy Iranian adults: the Tehran homocysteine survey (2003–2004)/a cross – sectional population based study

Authors: Hossein Fakhrzadeh, Sara Ghotbi, Rasoul Pourebrahim, Masoumeh Nouri, Ramin Heshmat, Fatemeh Bandarian, Alireza Shafaee, Bagher Larijani

Published in: BMC Public Health | Issue 1/2006

Login to get access

Abstract

Background

Elevated plasma total homocysteine is an independent risk factor for cardiovascular disease and a sensitive marker of the inadequate vitamin B12 and folate insufficiency. Folate and vitamin B12 have a protective effect on cardiovascular disease. This population based study was conducted to evaluate the plasma total homocysteine, folate, and vitamin B12 in healthy Iranian individuals.

Methods

This study was a part of the Cardiovascular Risk Factors Survey in the Population Lab Region of Tehran University has been designed and conducted based on the methodology of MONICA/WHO Project. A total of 1214 people aged 25–64 years, were recruited and assessed regarding demographic characteristics, homocysteine, folate, and vitamin B12 levels with interview, questionnaires, examination and blood sampling. Blood samples were gathered and analyzed according to standard methods.

Results

The variables were assessed in 1214 participants including 428 men (35.3%) and 786 women (64.7%). Age-adjusted prevalence of hyperhomocysteinemia (Hcy≥15 μmol/L) was 73.1% in men and 41.07% in women (P < 0.0001). Geometric mean of plasma homocysteine was 19.02 ± 1.46 μmol/l in men and 14.05 ± 1.45 μmol/l in women (P < 0.004) which increased by ageing. Age-adjusted prevalence of low serum folate level was 98.67% in men and 97.92% in women. Age-adjusted prevalence of low serum vitamin B12 level was 26.32% in men and 27.2% in women. Correlation coefficients (Pearson's r) between log tHcy and serum folate, and vitamin B12 indicated an inverse correlation (r = -0.27, r = -0.19, P < 0.0001, respectively).

Conclusion

These results revealed that the prevalence of hyperhomocysteinemia, low folate and vitamin B12 levels are considerably higher than other communities. Implementation of preventive interventions such as food fortification with folic acid is necessary.
Literature
1.
go back to reference Malinow MR: Homocysteine and arterial occlusive diseases. J Intern Med. 1994, 53: 603-607.CrossRef Malinow MR: Homocysteine and arterial occlusive diseases. J Intern Med. 1994, 53: 603-607.CrossRef
2.
go back to reference Lim HS, Heo YR: Plasma total homocysteine, folate, and vitamin B12 status in Korean adults. J Nutr Sci Vitaminol. 2002, 48: 290-297.CrossRefPubMed Lim HS, Heo YR: Plasma total homocysteine, folate, and vitamin B12 status in Korean adults. J Nutr Sci Vitaminol. 2002, 48: 290-297.CrossRefPubMed
3.
go back to reference Martin I, Obrador A, Gibert MJ, Hernanz A, Fuster A, Pintos C, Garcia A, Tur J: Folate status and a new repletion cut – off value in a group of healthy Majorcan woman. Clinical Nutrition. 2003, 22: 53-58. 10.1054/clnu.2002.0591.CrossRefPubMed Martin I, Obrador A, Gibert MJ, Hernanz A, Fuster A, Pintos C, Garcia A, Tur J: Folate status and a new repletion cut – off value in a group of healthy Majorcan woman. Clinical Nutrition. 2003, 22: 53-58. 10.1054/clnu.2002.0591.CrossRefPubMed
4.
go back to reference Alfthan G, Aro A, Gey KF: Plasma homocysteine and cardiovascular disease mortality. Lancet. 1997, 48: 349-397. Alfthan G, Aro A, Gey KF: Plasma homocysteine and cardiovascular disease mortality. Lancet. 1997, 48: 349-397.
5.
go back to reference Faraci FM: Hyperhomocysteinemia: a million ways to lose control. Aterioscler Thromb Vasc Biol. 2003, 23: 371-373. 10.1161/01.ATV.0000063607.56590.7F.CrossRef Faraci FM: Hyperhomocysteinemia: a million ways to lose control. Aterioscler Thromb Vasc Biol. 2003, 23: 371-373. 10.1161/01.ATV.0000063607.56590.7F.CrossRef
6.
go back to reference Rampersaud GC, Kauwell GP, Ailey LB: Folate: a key to optimizing health and reducing disease risk in the elderly. J Am Coll Nutr. 2003, 22: 1-8.CrossRefPubMed Rampersaud GC, Kauwell GP, Ailey LB: Folate: a key to optimizing health and reducing disease risk in the elderly. J Am Coll Nutr. 2003, 22: 1-8.CrossRefPubMed
7.
go back to reference Graham I: Homocysteine in health and disease. Annals of Internal Medicine. 1999, 3: 387-388.CrossRef Graham I: Homocysteine in health and disease. Annals of Internal Medicine. 1999, 3: 387-388.CrossRef
8.
go back to reference Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL: Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991–1994): Population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med. 1999, 131: 331-339.CrossRefPubMed Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL: Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991–1994): Population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med. 1999, 131: 331-339.CrossRefPubMed
9.
go back to reference Graham IM, OCallaghan P: The role of folic acid in the prevention of cardiovascular disease. Curr Opin Lipidol. 2000, 11: 577-587. 10.1097/00041433-200012000-00003.CrossRefPubMed Graham IM, OCallaghan P: The role of folic acid in the prevention of cardiovascular disease. Curr Opin Lipidol. 2000, 11: 577-587. 10.1097/00041433-200012000-00003.CrossRefPubMed
10.
go back to reference Verhaar MC, Stores E, Rabelink TJ: Folates and cardiovascular disease. Arterioscler Thromb Vas Biol. 2002, 22: 6-13. 10.1161/hq0102.102190.CrossRef Verhaar MC, Stores E, Rabelink TJ: Folates and cardiovascular disease. Arterioscler Thromb Vas Biol. 2002, 22: 6-13. 10.1161/hq0102.102190.CrossRef
11.
go back to reference Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RC, Alvarez JO, Macaluso M, Acton RT, Copeland RB, Cousins AL, et al: Plasma homocysteine, folate, and vitamin B12 concentrations and risk for early – onset coronary artery disease. Am J Clin Nutr. 1994, 59: 940-948.PubMed Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RC, Alvarez JO, Macaluso M, Acton RT, Copeland RB, Cousins AL, et al: Plasma homocysteine, folate, and vitamin B12 concentrations and risk for early – onset coronary artery disease. Am J Clin Nutr. 1994, 59: 940-948.PubMed
12.
go back to reference Morrison HI, Schaubel D, Desmeules M, Wigle DT: Serum folate and risk of fatal coronary heart disease. JAMA. 1996, 275: 1893-1896. 10.1001/jama.275.24.1893.CrossRefPubMed Morrison HI, Schaubel D, Desmeules M, Wigle DT: Serum folate and risk of fatal coronary heart disease. JAMA. 1996, 275: 1893-1896. 10.1001/jama.275.24.1893.CrossRefPubMed
13.
go back to reference Nygard O, Refsum H, Ueland PM, Vollset SE: Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Study. Am J Clin Nutr. 1998, 67: 263-270.PubMed Nygard O, Refsum H, Ueland PM, Vollset SE: Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Study. Am J Clin Nutr. 1998, 67: 263-270.PubMed
14.
go back to reference Ubbink JB, Becker PJ, Vermaak WJ, Delport R: Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clin Chem. 1995, 41: 1033-1037.PubMed Ubbink JB, Becker PJ, Vermaak WJ, Delport R: Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clin Chem. 1995, 41: 1033-1037.PubMed
15.
go back to reference Rasmussen K, Moller J, Lyngbak M, Pedersen AM, Dybkjaer L: Age- and gender-specific reference intervals for totall homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem. 1996, 42: 630-636.PubMed Rasmussen K, Moller J, Lyngbak M, Pedersen AM, Dybkjaer L: Age- and gender-specific reference intervals for totall homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem. 1996, 42: 630-636.PubMed
16.
go back to reference Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW, Wright JD, Johnson CL: Serum homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey (NHANES III). Am J Clin Nutr. 1999, 69: 482-489.PubMed Jacques PF, Rosenberg IH, Rogers G, Selhub J, Bowman BA, Gunter EW, Wright JD, Johnson CL: Serum homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey (NHANES III). Am J Clin Nutr. 1999, 69: 482-489.PubMed
17.
go back to reference Golbahar J, Rezaian G, Bararpour H: Distribution of plasma total homocysteine concentrations in the healthy Iranians. Clinical Biochemistry. 2004, 37: 149-151. 10.1016/j.clinbiochem.2003.10.005.CrossRefPubMed Golbahar J, Rezaian G, Bararpour H: Distribution of plasma total homocysteine concentrations in the healthy Iranians. Clinical Biochemistry. 2004, 37: 149-151. 10.1016/j.clinbiochem.2003.10.005.CrossRefPubMed
18.
go back to reference WHO MONICA Project Principal Investigators: The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol. 1988, 41: 105-114. 10.1016/0895-4356(88)90084-4.CrossRef WHO MONICA Project Principal Investigators: The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol. 1988, 41: 105-114. 10.1016/0895-4356(88)90084-4.CrossRef
19.
go back to reference WHO MONICA Project: Geographical variation in the major risk factors of coronary heart disease in men and women aged 25–64 years. World Health Stat Q. 1988, 41: 115-137. WHO MONICA Project: Geographical variation in the major risk factors of coronary heart disease in men and women aged 25–64 years. World Health Stat Q. 1988, 41: 115-137.
20.
go back to reference Selhub J, Rosenberg IH: Present knowledge in Nutrition. Folic acid. Edited by: Ziegler EE, Filer LJ. 1996, Washington, DC: ILSI Pr, 206-19. 7 Selhub J, Rosenberg IH: Present knowledge in Nutrition. Folic acid. Edited by: Ziegler EE, Filer LJ. 1996, Washington, DC: ILSI Pr, 206-19. 7
21.
go back to reference Herbert V: Modern Nutrition in Health and Disease. Folic acid. Edited by: Shils ME, Olson JA, Shike M, Ross AC. 1999, Baltimore: Williams & Wilkins, 433-446. 9 Herbert V: Modern Nutrition in Health and Disease. Folic acid. Edited by: Shils ME, Olson JA, Shike M, Ross AC. 1999, Baltimore: Williams & Wilkins, 433-446. 9
22.
go back to reference Weir DG, Scott JM: Modern Nutrition in Health and Disease. Vitamin B12 "cobalamin". Edited by: Shils ME, Olson JA, Shike M, Ross AC. 1999, Baltimore: Williams & Wilkins, 447-458. 9 Weir DG, Scott JM: Modern Nutrition in Health and Disease. Vitamin B12 "cobalamin". Edited by: Shils ME, Olson JA, Shike M, Ross AC. 1999, Baltimore: Williams & Wilkins, 447-458. 9
23.
go back to reference Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993, 270: 2693-2698. 10.1001/jama.270.22.2693.CrossRefPubMed Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993, 270: 2693-2698. 10.1001/jama.270.22.2693.CrossRefPubMed
24.
go back to reference Refsum H, Ueland PM, Nygard O, Vollset SE: Homocysteine and cardiovascular disease. Ann Rev Med. 1998, 49: 31-62. 10.1146/annurev.med.49.1.31.CrossRefPubMed Refsum H, Ueland PM, Nygard O, Vollset SE: Homocysteine and cardiovascular disease. Ann Rev Med. 1998, 49: 31-62. 10.1146/annurev.med.49.1.31.CrossRefPubMed
25.
go back to reference Nygrad O, Vollset SE, Refsum HM: Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995, 274: 1536-1533. Nygrad O, Vollset SE, Refsum HM: Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995, 274: 1536-1533.
26.
go back to reference Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G, et al: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997, 277: 1775-1781. 10.1001/jama.277.22.1775.CrossRefPubMed Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G, et al: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997, 277: 1775-1781. 10.1001/jama.277.22.1775.CrossRefPubMed
27.
go back to reference Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB: Homocysteine and cardiovascular disease: a systemic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol. 2002, 31: 59-70. 10.1093/ije/31.1.59.CrossRefPubMed Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB: Homocysteine and cardiovascular disease: a systemic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol. 2002, 31: 59-70. 10.1093/ije/31.1.59.CrossRefPubMed
28.
go back to reference Clarke R, Collins R: Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. J Cardiovasc Risk. 1998, 5: 249-255.PubMed Clarke R, Collins R: Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. J Cardiovasc Risk. 1998, 5: 249-255.PubMed
29.
go back to reference Brattstrom LE, Israelsson B, Jeppsson JO, Hultberg BL: Folic acid – an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest. 1988, 48: 215-221.CrossRefPubMed Brattstrom LE, Israelsson B, Jeppsson JO, Hultberg BL: Folic acid – an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest. 1988, 48: 215-221.CrossRefPubMed
30.
go back to reference Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ, Delport R, Potgieter HC: Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr. 1994, 124: 1927-1933.PubMed Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ, Delport R, Potgieter HC: Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr. 1994, 124: 1927-1933.PubMed
31.
go back to reference Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J: Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr. 1996, 64: 587-593.PubMed Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J: Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr. 1996, 64: 587-593.PubMed
32.
go back to reference Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B: Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med. 1994, 36: 633-641.CrossRef Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B: Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med. 1994, 36: 633-641.CrossRef
33.
go back to reference Koehler KM, Romero LJ, Stauber PM, Pareo-Tubbeh SL, Liang HC, Baumgartner RN, Garry PJ, Allen RH, Stabler SP: Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentrations in elderly men and women. J Am Coll Nutr. 1996, 15: 364-376.CrossRefPubMed Koehler KM, Romero LJ, Stauber PM, Pareo-Tubbeh SL, Liang HC, Baumgartner RN, Garry PJ, Allen RH, Stabler SP: Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentrations in elderly men and women. J Am Coll Nutr. 1996, 15: 364-376.CrossRefPubMed
34.
go back to reference Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B: Plasma homocysteine before and after methionine loading with regard to age, gender and menopausal status. Eur J Clin Investig. 1992, 22: 79-87.CrossRef Andersson A, Brattstrom L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B: Plasma homocysteine before and after methionine loading with regard to age, gender and menopausal status. Eur J Clin Investig. 1992, 22: 79-87.CrossRef
35.
go back to reference de Bree A: Dietary, lifestyle and genetic determinants of homocysteine and its relation with coronary heart disease. Thesis katholieke Universiteit Nijmegen. 2001, The Netherlands, 1: 187- de Bree A: Dietary, lifestyle and genetic determinants of homocysteine and its relation with coronary heart disease. Thesis katholieke Universiteit Nijmegen. 2001, The Netherlands, 1: 187-
36.
go back to reference Stein JH, McBride PE: Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening, and treatment. Arch Intern Med. 1998, 158: 1301-1306. 10.1001/archinte.158.12.1301.CrossRefPubMed Stein JH, McBride PE: Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening, and treatment. Arch Intern Med. 1998, 158: 1301-1306. 10.1001/archinte.158.12.1301.CrossRefPubMed
37.
go back to reference Guttormsen AB, Ueland PM, Svarstad E, Refsum H: Kinetic basis of hyper homocysteinemia in patients with chronic renal failure. Kidney Int. 1997, 52: 495-502.CrossRefPubMed Guttormsen AB, Ueland PM, Svarstad E, Refsum H: Kinetic basis of hyper homocysteinemia in patients with chronic renal failure. Kidney Int. 1997, 52: 495-502.CrossRefPubMed
38.
go back to reference Norlund L, Grubb A, Fex G, Leksell H, Nilsson JE, Schenck H, Hultberg B: The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med. 1998, 36: 175-178. 10.1515/CCLM.1998.032.CrossRefPubMed Norlund L, Grubb A, Fex G, Leksell H, Nilsson JE, Schenck H, Hultberg B: The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med. 1998, 36: 175-178. 10.1515/CCLM.1998.032.CrossRefPubMed
39.
go back to reference Tucker KL, Selhub J, Wilson PW, Rosenberg IH: Diatery pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study. J Nutr. 1996, 126: 3025-3031.PubMed Tucker KL, Selhub J, Wilson PW, Rosenberg IH: Diatery pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study. J Nutr. 1996, 126: 3025-3031.PubMed
40.
go back to reference van Asselt DZ, de Groot LC, van Staveren WA, Blom HJ, Wevers RA, Biemond I, Hoefnagels WH: Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr. 1998, 68: 328-334.PubMed van Asselt DZ, de Groot LC, van Staveren WA, Blom HJ, Wevers RA, Biemond I, Hoefnagels WH: Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr. 1998, 68: 328-334.PubMed
41.
go back to reference Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD: Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab. 1998, 83: 550-553. 10.1210/jc.83.2.550.CrossRefPubMed Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD: Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab. 1998, 83: 550-553. 10.1210/jc.83.2.550.CrossRefPubMed
42.
go back to reference Dawson DW, Waters HM: Malnutrition: folate and cobalamin deficiency. B J Biomed Sci. 1994, 51: 221-227. Dawson DW, Waters HM: Malnutrition: folate and cobalamin deficiency. B J Biomed Sci. 1994, 51: 221-227.
43.
go back to reference Misra A, Vikram NK, Pandey RM, Dwivedi M, Ahmad FU, Luthra K, Jain K, Khanna N, Devi JR, Sharma R, Guleria R: Hyperhomocysteinemia, and low intakes of folic acid and vitamin B12 in urban North India. Eur J Nutr. 2002, 41: 68-77. 10.1007/s003940200010.CrossRefPubMed Misra A, Vikram NK, Pandey RM, Dwivedi M, Ahmad FU, Luthra K, Jain K, Khanna N, Devi JR, Sharma R, Guleria R: Hyperhomocysteinemia, and low intakes of folic acid and vitamin B12 in urban North India. Eur J Nutr. 2002, 41: 68-77. 10.1007/s003940200010.CrossRefPubMed
45.
go back to reference Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 1999, 340: 1449-1454. 10.1056/NEJM199905133401901.CrossRefPubMed Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 1999, 340: 1449-1454. 10.1056/NEJM199905133401901.CrossRefPubMed
46.
go back to reference MRC Vitamin Research Group: Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991, 338: 131-137. 10.1016/0140-6736(91)90133-A.CrossRef MRC Vitamin Research Group: Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991, 338: 131-137. 10.1016/0140-6736(91)90133-A.CrossRef
47.
go back to reference Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc. 1995, 274: 1049-1057. 10.1001/jama.274.13.1049.CrossRef Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc. 1995, 274: 1049-1057. 10.1001/jama.274.13.1049.CrossRef
48.
go back to reference Choi SW, Mason JB: Folate and carcinogenesis: an integrated scheme. J Nutr. 2000, 130: 129-132.PubMed Choi SW, Mason JB: Folate and carcinogenesis: an integrated scheme. J Nutr. 2000, 130: 129-132.PubMed
49.
go back to reference Quinlivan EP, Gregory JF: Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr. 2000, 77: 221-225. Quinlivan EP, Gregory JF: Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr. 2000, 77: 221-225.
Metadata
Title
Total plasma homocysteine, folate, and vitamin b12 status in healthy Iranian adults: the Tehran homocysteine survey (2003–2004)/a cross – sectional population based study
Authors
Hossein Fakhrzadeh
Sara Ghotbi
Rasoul Pourebrahim
Masoumeh Nouri
Ramin Heshmat
Fatemeh Bandarian
Alireza Shafaee
Bagher Larijani
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2006
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-6-29

Other articles of this Issue 1/2006

BMC Public Health 1/2006 Go to the issue